Table 4.
Cox regression analysis for all-cause mortality
| HR | Univariate | HR | Multivariate | |||
|---|---|---|---|---|---|---|
| 95% CI | p | 95% CI | p | |||
| LGE presence (yes vs. no) | 3.9 | 1.5–9.9 | 0.005 | 5.3 | 1.5–18.1 | 0.009 |
| LGE mass (per 5%) | 1.00 | 0.96–1.1 | 0.8 | 0.9 | 0.8–1.1 | 0.4 |
| Age (per 5 years) | 1.05 | 0.97–1.1 | 0.3 | 1.08 | 0.97–1.2 | 0.2 |
| Sex (male vs. female) | 1.5 | 0.6–3.9 | 0.4 | 1.3 | 0.4–4.4 | 0.7 |
| NYHA functional class (III vs. II) | 1.9 | 0.7–4.8 | 0.2 | 1.8 | 0.7–4.9 | 0.2 |
| NT-proBNP (per doubling) | 1.3 | 0.9–1.8 | 0.2 | 1.0 | 1.0–1.0 | 0.6 |
| LVEF (per 5%) | 1.00 | 0.9–1.1 | 0.9 | 0.9 | 0.8–1.1 | 0.9 |
Statistical significance was considered achieved at a p value < 0.05
LGE late gadolinium enhancement, NYHA New York Heart Association, LVEF left ventricular ejection fraction, HR hazards ratio, CI confidence interval